yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Table
SPARQL
Graphs
2
2
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38031262-202E47DA-42DD-4C4C-B754-FA06D62A32B0
Q38031262-202E47DA-42DD-4C4C-B754-FA06D62A32B0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38031262-202E47DA-42DD-4C4C-B754-FA06D62A32B0
Splenomegaly in myelofibrosis--new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors
P2860
Q38031262-202E47DA-42DD-4C4C-B754-FA06D62A32B0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38031262-202E47DA-42DD-4C4C-B754-FA06D62A32B0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
83d7633d08882cf6f7674759467279b82fd2f1e5
P2860
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis.